Current medical news and unique business news for anyone who cares about the healthcare industry.
Tenet Healthcare says no thanks: Health Systems had upped its buyout offer by 21 percent to $4.06 billion, but hospital operator Tenet Healthcare rejected the bid. The two companies have been fighting over an appropriate financial deal since the fall.
Colon testing one too many? A new study found that many older Americans are getting unnecessary repeat colon cancer tests and Medicare is stuck with the tab. Only 27 percent of all study patients with frequent exams had symptoms that might have raised suspicion of cancer, including abdominal pain, change in bowel habits, and weight loss.
When Investment Rhymes with Canada
Canada has a proud history of achievement in the areas of science and technology, and the field of biomanufacturing and life sciences is no exception.
Heart patients beware of some pain relievers: New research suggests that even a temporary, short term use of NSAIDs, or nonsteroidal anti-inflammatory drugs, is unsafe. They include ibuprofen, naproxen, Voltaren, Celebrex and others. The study was published in Circulation, a journal of the American Heart Association.
Colorado medical firm closes as regulators probe: Heart Check America has closed its doors after state regulators notified the company that it violated state regulations. Scans of heart, lung, bone density and other imaging were being performed without doctors’ orders, and were not read by a radiologist, regulators found.
Pfizer’s pneumonia drug effective on older people: Prevnar 13, Pfizer’s pneumonia vaccine was found to be effective in two studies of adults over the age of 50. Pfizer’s Prevnar is approved for use in children up to 6 years of age, but the company has now applied for regulatory approval to broaden the product’s use.
Cancer survival differs by sexual orientation? A new study by Boston University researchers found that gay men have a higher prevalence of cancer compared with heterosexual men, while there was no significant difference in cancer prevalence by sexual orientation among women.
